ACA stock forecast, quote, news & analysis

ACA in upward trend: price rose above 50-day moving average on September 17, 2026

ACA moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 80%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 40 of 63 cases where ACA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.

The Momentum Indicator moved above the 0 level on September 17, 2026. You may want to consider a long position or call options on ACA as a result. In 66 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

Following a +0.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACA advanced for three days, in 198 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

ACA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 115 of 220 cases where ACA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 15 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ACA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 50 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.394) is normal, around the industry mean (17.035). P/E Ratio (32.467) is within average values for comparable stocks, (219.500). Projected Growth (PEG Ratio) (1.850) is also within normal values, averaging (3.183). Dividend Yield (0.001) settles around the average of (0.013) among similar stocks. P/S Ratio (2.444) is also within normal values, averaging (2.926).

The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

ACA paid dividends on July 31, 2026